Webster Stephen W
- SEC CIK
- 0001438421
No open-market purchases or sales filed in the past year.
Current role at each company
- NXTC NextCure, Inc.Directoras of Jun 22, 2026
- CGEM Cullinan Therapeutics, Inc.Directoras of Jun 18, 2026
- ELOX Eloxx Pharmaceuticals, Inc.Directoras of Jun 10, 2026
- GRTS Gritstone bio, Inc.Directoras of Apr 8, 2025
- TCRR TCR2 Therapeutics Inc.Directoras of Jun 1, 2023
Show 1 more company
- Nabriva Therapeutics plcDirectoras of Aug 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Webster Stephen W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Nabriva Therapeutics plc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 (view filing)6:20 PM ET | Aug 2 | 2 days | Webster Stephen WDirector | SSale | −7.83K | $0.19 | −$1.49K | −40.6%11.4K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Webster Stephen WDirector | SSale | −777 | $1.20 | −$932.4 | −3.9%19.3K after |